Wirral, United Kingdom

David John Duncalf

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Wirral, GB (2009 - 2015)
  • Little Neston, GB (2010 - 2015)
  • Liverpool, GB (2015 - 2020)

Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: David John Duncalf: Innovator in Antiviral Compositions

Introduction

David John Duncalf is a notable inventor based in Wirral, GB. He has made significant contributions to the field of antiviral drug preparations, holding a total of 9 patents. His work focuses on innovative compositions that enhance the effectiveness of antiviral treatments.

Latest Patents

Among his latest patents, Duncalf has developed antiviral compositions that provide a unique formulation. Each composition comprises at least one water-insoluble antiviral drug and at least one water-soluble carrier material. The water-insoluble antiviral drug is dispersed through the water-soluble carrier material in nano-disperse form. This invention also includes processes for preparing the compositions and drug preparations, as well as aqueous nano-dispersions obtained by combining water and the compositions.

Career Highlights

Throughout his career, Duncalf has worked with various companies, including Conopco, Inc. His experience in the industry has allowed him to refine his expertise in developing antiviral solutions. His innovative approach has positioned him as a key figure in the field of pharmaceutical inventions.

Collaborations

Duncalf has collaborated with notable professionals in his field, including Steven Paul Rannard and Alison Jayne Foster. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

David John Duncalf's contributions to antiviral compositions demonstrate his commitment to innovation in the pharmaceutical industry. His work continues to impact the development of effective antiviral treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…